Remove 2023 Remove Communication Remove Packaging
article thumbnail

Chandigarh Calling!

Express Pharma

The latest in this series, Chandigarh Pharma Summit 2023 was successfully hosted by Express Pharma recently. In this article, we delve into the highlights of the Chandigarh Pharma Summit 2023, and showcase the key takeaways and insights from the presentations and discussions at the event.

Packaging 104
article thumbnail

FDA’s OPDP Issues Third Letter of 2023

Eye on FDA

The communications vehicle in question was a social media sponsored posting. OPDP took issue with three specific aspects of the promotional communication. First, while presenting the indication in the posting, there was no risk information included in the communication. Pharma communicators take note.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Labelling of Dispensed Medicine

RX Note

capitals, bolding and highlighting) to communicate important information. NOTE: The dispensing label must not obscure the active ingredient(s), strength, and expiry date as printed on the manufacturer's packaging. Complete the course" for antibiotics, "May cause drowsiness" for sedating drugs, etc.)

article thumbnail

How ready are you? Preparing for the impact of EU GMP Annex 1 on primary packaging

European Pharmaceutical Review

While it officially applies to the manufacture of sterile medicinal products in the European Union, the revised EU Good Manufacturing Practice (GMP) Annex 1 effectively reset the benchmark for quality standards across the globe on 25 August 2023. Register your details to read more The post How ready are you?

article thumbnail

How Pharmacies Can Prep Now for the 2023 DSCSA Requirements

National Association of Boards of Pharmacy

Well, believe it or not, we are just a little more than a year away from that November 2023 deadline. One requirement that is included in Title II of the Act calls for product tracing at the package level, which had not been explored widely by the industry until recently. How can you prepare for November 27, 2023?

article thumbnail

AI in pharmaceutical development: hype or panacea?

European Pharmaceutical Review

AI-based optic systems, for example, can enhance defect screening in manufacturing by scanning for packaging defects. 2023; 621(7979): 467470. 2023; 1(2): 100011. 2023; 4(2): E137-E148. Nature Communications. 2023 [cited 2025Feb]. Internet] Fierce Biotech. 2024 [cited 2025Feb]. Available from: [link] 3.

article thumbnail

FDA issues draft guidance on alternative tools for facility assessments

European Pharmaceutical Review

Assessing drug manufacturing facilities using alternative tools The FDA stated in the guidance that all manufacturing, packaging, and control sites for drug substance and drug product facilities are expected to be ready for inspection at the time of application submission.